Dividend compounder review

GMAB

Genmab AS · NASDAQ · US

Healthcare · Biotechnology

Chart Factor Intelligence Back to Screener
Score45.50/100
Confidence82.00/100
DecisionInsufficient Data
RatingAvoid
Scoring

Quality breakdown

Dividend Reliability 0.0 / 25 Payment history, cuts, growth, and regularity.
Dividend Sustainability 17.0 / 20 Payout, free cash flow, dividend cover, and debt.
Business Quality 20.5 / 25 Scale, cash generation, growth, margins, and returns.
Valuation Discipline 8.0 / 15 Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend 0.0 / 15 Trend line, long return history, and drawdown control.
Metrics

Dividend and business context

Dividend Years0
Dividend Yield0.00%
Payout Ratio0.0%
Dividend Cut 5YNo
Net Income$963.0M
Free Cash Flow$1.1B
FCF Covers DividendUnknown
Debt / Equity0.94
P/E19.0
Revenue Growth 5Y-18.1%
Net Margin21.0%
ROE15.0%
Price vs Trend-13.9%
3Y Return-34.7%
5Y Return-40.4%
CurrencyUSD
Warnings

Review flags

No usable dividend history found.
Dividend diary

Activity record

GMAB dividend review warning Warning · Warning

No usable dividend history found.